NEW YORK (GenomeWeb News) – Caliper Life Sciences today announced a settlement with Carestream Health, ending a legal dispute over imaging technologies.
The announcement puts an end to two lawsuits Caliper and Carestream filed against each other alleging patent infringement. In the first lawsuit, filed in February 2010, Caliper sued Carestream alleging the Rochester, NY-based firm's Kodak in vivo molecular imaging systems infringed seven patents owned by Stanford University and exclusively licensed to Caliper subsidiary Xenogen.
In July 2010, Carestream filed a countersuit alleging that Caliper's Lumina XR system infringed a patent issued to Carestream a month earlier.
As part of the settlement, Caliper and Carestream have agreed to dismiss all claims and counterclaims, and Carestream will not market or sell in vivo optical imaging systems for certain applications covered by the Stanford patents licensed to Xenogen and Caliper.
Carestream also will not assert that the Lumina XR system as currently configured infringes any of its patents.
Financial terms of the settlement were not disclosed.